Summary
BioRestorative Therapies, Inc. (BRT), formerly Stem Cell Assurance, Inc is a biotechnology company that develops therapeutic products and medical therapies using cell and tissue protocols. The company conducts stem cell programs which include brtxDISC and ThermoStem. Its brtxDISC is the lead therapeutic product designed to offer a non-surgical treatment for chronic lumbar disc disease such as bulging and herniated discs. The company’s ThermoStem program develops brown fat stem cell-based therapy which is used for the treatment of type 2 diabetes, obesity, and other metabolic disorders such as heart disease, and hypertension. BRT is headquartered in Melville, New York, the US.
BioRestorative Therapies, Inc. (BRTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
BioRestorative Therapies, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
BioRestorative Therapies, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
BioRestorative Therapies, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
BioRestorative Therapies, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
BioRestorative Therapies, Inc., Medical Devices Deals, 2010 to YTD 2016 9
BioRestorative Therapies, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
BioRestorative Therapies, Inc., Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 11
BioRestorative Therapies Enters into Research Agreement with Pfizer 12
BioRestorative Therapies Enters Into R&D Agreement With Rohto Pharma 13
BioRestorative Therapies Enters Into Research Agreement With University of Utah 14
Licensing Agreements 15
BioRestorative Therapies Enters Into Licensing Agreement With Regenerative Sciences For Stem Cell Disc And Spine Procedure 15
BioRestorative Therapies Enters Into Licensing Agreement With The University of Utah 17
Equity Offering 18
BioRestorative Therapies to Raise up to USD4 Million in Public Offering of Shares and Warrants 18
BioRestorative Therapies Completes Private Placement Of Shares For US$0.5 Million 20
Stem Cell Assurance Completes Private Placement of US$0.14 Million 21
Stem Cell Assurance Announces Private Placement For US$1 Million 22
Stem Cell Assurance Completes First Tranche Of Private Placement With MDwerks 23
Debt Offering 24
Stem Cell Assurance Secures Debt Financing Of US$1.3 Million 24
BioRestorative Therapies, Inc. - Key Competitors 25
Key Employees 26
Locations And Subsidiaries 27
Head Office 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28
List of Tables
BioRestorative Therapies, Inc., Pharmaceuticals & Healthcare, Key Facts, 2015 1
BioRestorative Therapies, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
BioRestorative Therapies, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
BioRestorative Therapies, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
BioRestorative Therapies, Inc., Deals By Therapy Area, 2010 to YTD 2016 8
BioRestorative Therapies, Inc., Medical Devices Deals, 2010 to YTD 2016 9
BioRestorative Therapies, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 11
BioRestorative Therapies Enters into Research Agreement with Pfizer 12
BioRestorative Therapies Enters Into R&D Agreement With Rohto Pharma 13
BioRestorative Therapies Enters Into Research Agreement With University of Utah 14
BioRestorative Therapies Enters Into Licensing Agreement With Regenerative Sciences For Stem Cell Disc And Spine Procedure 15
BioRestorative Therapies Enters Into Licensing Agreement With The University of Utah 17
BioRestorative Therapies to Raise up to USD4 Million in Public Offering of Shares and Warrants 18
BioRestorative Therapies Completes Private Placement Of Shares For US$0.5 Million 20
Stem Cell Assurance Completes Private Placement of US$0.14 Million 21
Stem Cell Assurance Announces Private Placement For US$1 Million 22
Stem Cell Assurance Completes First Tranche Of Private Placement With MDwerks 23
Stem Cell Assurance Secures Debt Financing Of US$1.3 Million 24
BioRestorative Therapies, Inc., Key Competitors 25
BioRestorative Therapies, Inc., Key Employees 26
List of Figures
BioRestorative Therapies, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
BioRestorative Therapies, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
BioRestorative Therapies, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
BioRestorative Therapies, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
BioRestorative Therapies, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
BioRestorative Therapies, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
BioRestorative Therapies, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
BioRestorative Therapies, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
BioRestorative Therapies, Inc., Medical Devices Deals, 2010 to YTD 2016 9
